The Fanconi Anemia Research Fund Inc. / Appendix A The Fanconi Anemia Research Fund / Hologic / Appendix A Sponsor / CellPath Ltd / Rovers Medical Devices B.V. / /
Country
Germany / Netherlands / United States / United Kingdom / /
Currency
pence / /
Event
FDA Phase / Second Stock Issuance / /
Facility
Hospital Hygiene / laboratory of Prof. Biesterfeld / laboratory of Prof. Brakenhoff / Camp Sunshine / laboratory of Prof. Henrich / University of Dusseldorf / /
IndustryTerm
oral cancer diagnosis protocol / social media sites / body systems / healthcare providers / alcohol-based fixing solution / /
Fanconi Anemia Research Fund / World Health Organization / Health Organization Chapter / Patient Organization for Fanconi Anemia / Institute for Medical Microbiology and Hospital Hygiene / University of Dusseldorf / Board of Directors and Scientific / /
Person
Amy Frohnmayer / Guido Fanconi / Eunike Velleuer / Brakenhoff / Ralf Dietrich / Laura Hays / /
Position
Executive Director / Advisors / study coordinator / designated study investigator / participant and designated treating physician / local physician for further investigation / treating physician / local pathologist / pediatrician / Director and scientific advisors / /
Product
Karl Storz Endoscopic Oral Documentation System / who / WHO oral / SCC / /
Technology
WHO oral cancer diagnosis protocol / transplantation / cancer detection / /
Study Title Reducing the burden of squamous cell carcinoma in Fanconi anemia PREAMBLE Fanconi anemia (FA), named for Swiss pediatrician, Guido Fanconi, is a rare genetic disease that leads to bone marrow failure. Though